News
Hosted on MSN1mon
The Ozempic boom could be bad news for restaurants as more than half of GLP-1 users report cutting back on dining out, report finds - MSNIn February 2024, Lars Fruergaard Jørgensen, the CEO of Ozempic maker Novo Nordisk, said he was fielding calls from “scared” food-company executives about the impact of the drug on the ...
Food. All-you-can’t-eat: GLP-1 drugs pose new challenges for restaurants, but how do they work? The rise of GLP-1 weight loss drugs, such as Ozempic and Wegovy, means people are dining out less ...
Patients have reported dental issues like tooth decay and dry mouth after taking GLP-1s like Ozempic for weight loss, though no scientific evidence confirms this connection.
The science behind Ozempic’s effects. Ozempic’s mechanism of action is multifaceted. The medication mimics a hormone called GLP-1, which influences both hunger and mood.
How Ozempic is changing the way America eats, travels and lives By . Eric Spitznagel. Published Nov. 30, 2024, 11:30 a.m. ET. ... Impact Analytics, a retail forecasting company, ...
Ozempic may have a positive impact on physical intimacy. Initially approved to treat type-2 diabetes, drugs like Ozempic and Wegovy continue to have unanticipated benefits. Kay Wicker.
Group Dining on Ozempic? It’s Complicated. As the use of GLP-1s soars in popularity, diners are wrestling with new restaurant etiquette dilemmas — and adjusting accordingly.
A new study explains how GLP-1 medications like Ozempic impact a person’s food choices. Here, experts break down the findings and what they may mean.
The Ozempic boom could be bad news for restaurants as more than half of GLP-1 users report cutting back on dining out, report finds Sasha Rogelberg Updated June 4, 2025 at 1:44 PM ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results